Newsroom

Immitra Bio receives CHF 150,000 from Venture Kick to reimagine stem cell therapy for rare diseases

15.06.2026

The ETH spin-off Immitra Bio has received CHF 150,000 from Venture Kick to develop a new treatment approach for rare genetic diseases. The biotech startup aims to replace complex stem cell transplantation procedures with a single injection, ... En savoir plus

PolaSight receives CHF 40,000 from Venture Kick to advance rapid tissue characterization in pathology

15.06.2026

PolaSight receives CHF 40,000 from Venture Kick to advance PolaOne, its AI-powered polarimetric imaging platform for pathology. The technology enables pathologists to characterize fresh tissue in just 60 seconds without staining or consumab ... En savoir plus

Inside the Jury Room: The Founders Who Stand Out Are Usually the Best Prepared by Caroline Gueissaz

11.06.2026

A Venture Kick jury session lasts only a few minutes, but experienced investors and entrepreneurs often form their first impression almost immediately. Surprisingly, that impression is not always created by groundbreaking technology or ambi ... En savoir plus

En savoir plus

Twitter

Youtube

Facebook

 

Contact medias

Pour toute question ou demande médias, veuillez envoyer un email à notre équipe de communication. Si vous avez une question d’ordre général sur Venture Kick, veuillez voir notre page contact.

Vous pouvez obtenir davantage d’informations sur Venture Kick ici ou télécharger le rapport annuel ici.